Osteoporosis Flashcards
meds that increase fracture risk
aromatase inhibitors
HAART
cyclosporin
corticosteroids >3mths
loop diuretics
PPIs
SSRIs
thiazolidinediones
chemo
high doses of Vit A
depo medroxy progesterone
Calcium and vitamin D recommendations for osteoporosis
calcium through diet
vit d 800-2000IU/day for individuals who are >50 years of age and at risk for osteoporosis
bisphosphonates
alendronate, risedronate, zolendronate
mainstay of tx, 40-60% reduction in frcture risk
MOA: inhibit osteoclast bone resorption, retained in bone and benefits maintain after dc
take on empty stomach, 30 min before food, full glass water, don’t lie down 30min after (ACTONEL DR IS RECOMMENDED AFTER BREAKFAST)
AE: GI upset, taste disturbance, nighttime leg cramps, ONJ (do dental work before), atypical femoral bone fractures
Drug holidays after 3-5y may be considered unless high risk (previous spine/hip fracture), to resume in 1-3y after remeasuring BMD
Denosumab
Biologic RANK-Ligand inhibitor - reduces osteoclast formation
BMD goes back down upon D/C so drug holidays not rec
AE: eczema, serious infections, hypocalcemia in impaired renal function, ONJ
Raloxifene
SERM; E antagonist in breast and uterus, agonist in
bone and lipid
prevents postmenopausal bone loss
AE: leg cramps, hot flashes
Caution: inc VTE risk
Teriparatide
anabolic agent (parathyroid hormone analogue) SC
max 24mth use due to inc osteosarcoma risk
AE: ortho hypo
tools to estimate fracture risk
FRAX, CAROC
definition of osteoporosis
low BMD; T-score<2.5 and fracture risk factors
medications associated with increased risk of fractures:
aromatase inhibitors, anticoagulants (unfractionated and low molecular weight heparins), antiretroviral
therapy, cyclosporine, corticosteroid therapy (>3 mths/y cumulative at a prednisone-equivalent dose ≥7.5 mg daily), loop
diuretics, PPIs, SSRIs, thiazolidinediones, chemotherapy and high doses of vitamin A.
non-pharms
exercise
fall prevention measures
smoking cessation
avoid alcohol (>2 /day) and caffeine (>4/day)
adequate protein, calcium and vitamin D intake
why is hormone therapy no longer recommended for prevention of fractures?
due to increased risk of breast cancer and heart disease
first line options for OP
Bisphosphonates, denosumab, estrogen and
teriparatide are all considered first-line options. Raloxifene is more second line.